Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07243080
Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention
Comparison Between the Efficacy of Rivaroxaban vs Enoxaparin in Post-Operative Deep Venous Thrombosis Prophylaxis After Exploratory Laparotomy
Sponsor: King Edward Medical University
Conditions
Deep Venous Thromboses Laparotomy Patients
Interventions
Enoxaparin 40 mg SC rivaroxaban (10mg)
Updated 1 time since 2025 Last updated: Nov 19, 2025 Started: Oct 10, 2025 Primary completion: Nov 10, 2025 Completion: Nov 15, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Deep Venous Thromboses and Laparotomy Patients and is currently actively recruiting participants. King Edward Medical University leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- King Edward Medical University
- Mayo Hospital Lahore
Data source: Mayo Hospital Lahore
For direct contact, visit the study record on ClinicalTrials.gov .